|
Delayed
Bombay S.E.
04:15:05 02/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 134.80 INR | -1.21% |
|
+6.02% | +87.51% |
| 10-16 | Zim Laboratories Limited Receives Tga Gmp Certification for Its Manufacturing Facility | CI |
| 09-18 | ZIM Laboratories Limited Incorporates Wholly Owned Subsidiary In Chile | CI |
| Market Cap | 7.32B 77.11M 69.06M 63.52M 57.56M 108M 110M 758M 304M 3.85B 289M 283M 12.15B | P/E 2025 |
32.1x | P/E 2026 | 50.3x |
|---|---|---|---|---|---|
| Enterprise Value | 8.18B 86.2M 77.2M 71.01M 64.34M 120M 123M 847M 340M 4.31B 324M 317M 13.58B | EV / Sales 2025 |
1.34x | EV / Sales 2026 | 1.09x |
| Free-Float |
28.77% | Yield 2025 * |
-
| Yield 2026 | - |
Bombay S.E.INR
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| ZIMLAB | Delayed | |
NSE India S.E.
| ZIMLAB | End-of-day quote |
Last Transcript: ZIM Laboratories Limited
| 1 day | -1.21% | ||
| 1 week | +6.02% | ||
| Current month | -1.21% | ||
| 1 month | -1.06% | ||
| 3 months | +21.17% | ||
| 6 months | +43.47% | ||
| Current year | +87.51% |
| 1 week | 126.6 |  | 143.55 |
| 1 month | 121.05 | | 160.1 |
| Current year | 59.72 | | 160.1 |
| 1 year | 59.72 | | 160.1 |
| 3 years | 59.72 | | 160.1 |
| 5 years | 36.37 | | 160.1 |
| 10 years | 14 | | 160.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Anwar Siraj Daud
CEO | Chief Executive Officer | - | 31/12/2001 |
| Director of Finance/CFO | - | 31/03/2019 | |
| Director of Finance/CFO | - | 31/12/1990 |
| Director | Title | Age | Since |
|---|---|---|---|
Anwar Siraj Daud
CHM | Chairman | - | 31/12/1989 |
| Director/Board Member | - | 31/12/1990 | |
Prakash Sapkal
BRD | Director/Board Member | - | 31/12/2012 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.21% | +6.02% | +84.53% | +12.52% | 77.11M | |
| +3.19% | +11.31% | +64.28% | +155.66% | 1,263B | |
| -0.73% | +3.56% | +44.65% | +83.74% | 658B | |
| +1.41% | +3.24% | +35.25% | +106.98% | 521B | |
| +0.42% | +3.20% | +55.81% | +69.71% | 391B | |
| +2.18% | +2.93% | +73.90% | +45.38% | 369B | |
| +1.12% | +4.52% | +34.76% | +57.00% | 307B | |
| +6.96% | +8.86% | +11.95% | +35.06% | 290B | |
| +1.15% | +6.09% | +56.15% | +78.66% | 252B | |
| +3.06% | +9.38% | +42.48% | +112.84% | 212B | |
| Average | +1.76% | +6.09% | +50.38% | +75.76% | 426.2B | |
| Weighted average by Cap. | +2.01% | +6.60% | +50.51% | +99.19% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 3.79B 39.93M 35.76M 32.89M 29.8M 55.71M 56.76M 392M 157M 1.99B 150M 147M 6.29B | 3.74B 39.43M 35.31M 32.48M 29.43M 55.02M 56.05M 387M 156M 1.97B 148M 145M 6.21B |
| Net income | 122M 1.28M 1.15M 1.06M 956K 1.79M 1.82M 12.59M 5.05M 63.99M 4.81M 4.71M 202M | 58.38M 615K 551K 507K 459K 858K 874K 6.04M 2.42M 30.71M 2.31M 2.26M 96.85M |
| Net Debt | 1.16B 12.19M 10.92M 10.04M 9.1M 17.01M 17.33M 120M 48.08M 609M 45.75M 44.78M 1.92B | 863M 9.09M 8.14M 7.49M 6.78M 12.68M 12.92M 89.3M 35.85M 454M 34.11M 33.39M 1.43B |
Employees
632
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/11/26 | ₹134.80 | -1.21% | 175 |
| 30/10/26 | ₹136.45 | -0.15% | 4,839 |
| 29/10/26 | ₹136.65 | -3.63% | 4,488 |
| 28/10/26 | ₹141.80 | +6.30% | 11,197 |
| 27/10/26 | ₹133.40 | +4.92% | 6,926 |
- Stock Market
- Stocks
- ZIMLAB Stock
Select your edition
All financial news and data tailored to specific country editions
